Bearish
Mizuho Cuts PT on ADMA Biologics Inc. (ADMA) to $24 From $30
Mizuho has lowered its price target on ADMA Biologics Inc. (ADMA) to $24 from $30, while maintaining an Outperform rating. This adjustment comes ahead...
Mizuho has lowered its price target on ADMA Biologics Inc. (ADMA) to $24 from $30, while maintaining an Outperform rating. This adjustment comes ahead...
Bearish
Cantor Fitzgerald downgraded ADMA Biologics Inc. (ADMA) to Neutral from Overweight after discussions with investors regarding a short report alleging ...
Mizuho has cut its price target on ADMA Biologics Inc. (ADMA) from $30 to $24, while maintaining an Outperform rating. This adjustment follows a broad...